Introduction
============

Myotonic dystrophy (DM) is a progressive multi-systemic disease consisting of highly heterogeneous clinical syndromes, affecting \~1 in 8,000 people globally ([@b1-mmr-16-04-3737]). It has two subtypes: DM1 and DM2. DM1 is primarily attributed to the mutation of a CTG expansion residing in the 3′-untranslated region of the dystrophia myotonica-protein kinase (DMPK) gene, whereas DM2 is ascribed to an untranslated CCTG expansion in the cellular retroviral nucleic acid binding protein 1/zinc finger 9 (CNBP) gene ([@b2-mmr-16-04-3737]). Several body components are affected by the disease, including skeletal muscles, the central nervous system, the heart and the eyes ([@b3-mmr-16-04-3737]). DM causes various ocular syndromes, such as early onset cataracts, external ophthalmoplegia and pigmentary retinopathy ([@b4-mmr-16-04-3737],[@b5-mmr-16-04-3737]).

DM1 and DM2 share many clinical features, and their underlying mechanisms are often investigated jointly. It has been reported that the stability of mutant RNAs (CUG and CCUG) in DM1 and DM2 is increased as a consequence of deficiency of RNA helicase p68 ([@b6-mmr-16-04-3737]). Dysregulation of intracellular calcium homeostasis in DM1 and DM2 myotubes has been identified to be associated with the aberrant splicing of Ca^2+^ handling genes ([@b7-mmr-16-04-3737]). Bachinski *et al* ([@b8-mmr-16-04-3737]) suggested that DM1 and DM2 are largely identical, as they are associated with dysregulated expression of genes in skeletal muscles. Previous studies have yielded significant findings concerning the molecular mechanisms of DM1 and DM2 ([@b9-mmr-16-04-3737],[@b10-mmr-16-04-3737]). However, little attention has been paid to the molecular mechanisms of DM1 and DM2 cataracts. DM1 and DM2 cataracts are almost identical in appearance and age of onset ([@b11-mmr-16-04-3737],[@b12-mmr-16-04-3737]). Rhodes *et al* ([@b13-mmr-16-04-3737]) demonstrated that upregulated interferon-regulated genes and the type 1 interferon signaling pathway may be involved in the common mechanism of DM1 and DM2 cataracts. Further efforts are required to unveil the underlying molecular mechanisms.

With the aid of high output microarray analysis, the present study identified differentially expressed genes (DEGs) between DM1 and non-DM cataracts samples, and between DM2 and non-DM cataracts samples. Gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed to investigate the biological functions and pathways that may involve the DEGs. Furthermore, the present study examined potential micro (mi)RNAs that may be involved in DM1 and DM2 by constructing a microRNA (miRNA)-gene network for DM1 and DM2, respectively.

Materials and methods
=====================

### Microarray dataset

The present study is a secondary study using the microarray dataset (E-MEXP-3365) ([@b13-mmr-16-04-3737]) downloaded from the Array Express database (<http://www.ebi.ac.uk/arrayexpress>) ([@b14-mmr-16-04-3737]), including 3 lens epithelial samples from DM1 cataract patients, 3 lens epithelial samples from DM2 cataract patients and 4 non-DM lens epithelial samples (control).

### Data preprocessing and identification of DEGs

The microarray data were preprocessed using the lumi Bioconductor package version 2.3 ([@b15-mmr-16-04-3737],[@b16-mmr-16-04-3737]). Each probe was mapped to its corresponding gene, followed by background correction and quartile data normalization. If a probe corresponded to \>1 gene, the probe would be deleted. When several probes mapped to one gene, the mean expression values of these probes were calculated as the expression value of the gene.

Differentially expressed genes were identified between DM1 cataract samples and non-DM cataract samples, and between DM2 cataract and non-DM cataract samples, using a t-test. The strict cutoff was set at fold change (\|logFC\|)\>2 and false discovery rate (FDR)\<0.05.

### GO and KEGG pathway enrichment analysis

In order to investigate the biological function involving the DEGs identified in the DM1 and DM2 cataracts, GO ([@b17-mmr-16-04-3737]) and KEGG ([@b18-mmr-16-04-3737]) pathway enrichment analysis was performed using Database for Annotation, Visualization and Integrated Discovery (<https://david.ncifcrf.gov/tools.jsp>) ([@b19-mmr-16-04-3737]). Significant GO terms and KEGG pathways (adjusted P≤0.05, gene number ≥2) were identified. There were 3 types of GO terms: Biological process (BP), cellular component (CC) and molecular function (MF).

### Construction of miRNA-DEG networks and analysis of network modules

Potential miRNAs that may be involved in regulating the DEGs identified in MD1 and MD2 cataract S were predicted using 7 algorithms, including PicTar ([@b20-mmr-16-04-3737]), DIANA-microT ([@b21-mmr-16-04-3737]), miRanda ([@b22-mmr-16-04-3737]), miRBase ([@b23-mmr-16-04-3737]), RNAhybrid ([@b24-mmr-16-04-3737]), RNA22 ([@b25-mmr-16-04-3737]) and TargetScan ([@b26-mmr-16-04-3737]). Only the miRNAs that were validated using at least 3 out of the 7 algorithms were selected. With the predicted miRNAs and DEGs, a miRNA-gene network was constructed for DM1 and DM2, respectively, using Cytoscape software version 3.2.0 ([@b27-mmr-16-04-3737]). In the network, a node denoted a gene or a miRNA; an undirected link represented an interaction between two genes, or between a gene and a miRNA. The degree of a node referred to the number of interactions of a gene or a miRNA. Furthermore, significant network modules were extracted from the network using Mcode plugin in Cytoscape ([@b27-mmr-16-04-3737]) (cutoff value: Degree ≥2) and analyzed.

Results
=======

### Identification of DEGs

A total of 223 DEGs were screened between DM1 cataract and non-DM cataract samples. A total of 303 DEGs were screened between DM2 cataract and non-MD cataract samples. Furthermore, 172 DEGs were shared by DM1 and DM2 cataracts.

### GO and KEGG pathway enrichment analysis

GO enrichment analysis revealed that most of significant CC and MF terms were common to DM1 and DM2 cataracts ([Tables I](#tI-mmr-16-04-3737){ref-type="table"} and [II](#tII-mmr-16-04-3737){ref-type="table"}). The overlapped MF terms were related to nucleotide binding and ribonucleotide binding. With regards to BP terms, DEGs in DM1 cataracts were significantly enriched with intracellular transport, cell cycle, mRNA metabolic process, RNA processing and vesicle-mediated transport ([Table I](#tI-mmr-16-04-3737){ref-type="table"}), whereas the DEGs in DM2 cataract were significantly associated with regulation of apoptosis, regulation of programmed cell death, regulation of cell death, intracellular transport and vesicle-mediated transport ([Table II](#tII-mmr-16-04-3737){ref-type="table"}).

The KEGG pathway enrichment analysis revealed that the amyotrophic lateral sclerosis and Alzheimer\'s disease signaling pathways were shared by DM1 and D2 cataracts. Furthermore, DEGs in DM1 cataracts were significantly enriched with calcium signaling, and markers from the Wnt and axon guidance signaling pathways ([Table III](#tIII-mmr-16-04-3737){ref-type="table"}), whereas DEGs in DM2 cataracts were markedly associated with the adherens junction signaling pathway ([Table IV](#tIV-mmr-16-04-3737){ref-type="table"}).

### Analysis of miRNA-gene networks

In the current study, a total of 345 miRNAs were predicted to be associated with the DEGs identified in DM1 cataracts, which constituted a total of 1,022 miRNA-target gene pairs. The DEGs in DM1 cataracts were predicted to be regulated by 371 miRNAs, and a total of 1,357 miRNA-target gene pairs were obtained.

For the purpose of deciphering the associations between DEGs, and between DEGs and the predicted miRNAs, an miRNA-gene network was constructed for DM1 ([Fig. 1](#f1-mmr-16-04-3737){ref-type="fig"}) and DM2 ([Fig. 2](#f2-mmr-16-04-3737){ref-type="fig"}). A total of three modules were extracted from the miRNA-gene network for DM1 cataracts. As presented in [Fig. 3](#f3-mmr-16-04-3737){ref-type="fig"}, miR-197, miR-29b, miR-29c, miR-130a and miR-130b were included in the network modules. A total of seven modules were extracted from the miRNA-gene network for DM2 cataracts ([Fig. 4](#f4-mmr-16-04-3737){ref-type="fig"}). miR-197, miR-29c, miR-29c, miR-152, miR-302d, miR-302d, miR-372, miR-20a, miR-20b, miR-133a, miR-133b, miR-148a, miR-148b and miR-515-3p were involved in these network modules. miR-197 and miR-29c were shared by the network modules of DM1 and DM2.

Discussion
==========

There are limited studies specifically focused on the molecular mechanisms of DM1 and DM2 cataracts. The present study identified 223 DEGs in DM1 cataracts and 303 DEGs in DM2 cataracts. Notably, a total of 172 overlapped DEGs were identified in DM1 and in DM2 cataracts. They shared several identical significant GO terms, but there were additionally some GO terms specific to DM1 or DM2 cataracts. DEGs in DM1 cataracts were significantly enriched in the calcium, Wnt and axon guidance signaling pathways, whereas DEGs in DM2 cataracts were significantly associated with the adherens junction signaling pathway. One highlight of the current study was the construction of an miRNA-gene network for DM1 and DM2 cataracts. miR-197, miR-29b, miR-29c, miR-130a and miR-130b were included in the three network modules extracted from the miRNA-gene network for DM1 cataracts. miR-197, miR-29c, miR-29c, miR-152, miR-302d, miR-372, miR-20a, miR-20b, miR-133a, miR-133b, miR-148a, miR-148b and miR-515-3p were involved in the seven network modules extracted from the miRNA-gene network for DM2 cataract. Notably, miR-197 and miR-29c were shared between DM1 and DM2 cataracts.

It has been demonstrated that DM1 and DM2 share several clinical and genetic features ([@b2-mmr-16-04-3737]). Both of them are toxic RNA diseases. Rhodes *et al* ([@b13-mmr-16-04-3737]) identified a high proportion of overlapped dysregulated genes in DM1 and DM2 cataracts, and suggested the involvement of the innate immune response and interferon signaling in their common underlying mechanisms. The present study demonstrated that DM1 and DM2 cataracts shared 172 DEGs. Furthermore, the two forms of DM cataracts were associated with identical CC and MF terms associated with nucleotide binding and ribonucleotide binding in the present study. In addition, they were associated intracellular transport and vesicle-mediated transport. These findings indicated that nucleotide binding, ribonucleotide binding, intracellular transport and vesicle-mediated transport may be implicated in the common molecular mechanisms underlying DM1 and DM2 cataracts.

DM1 and DM2 are two genetically distinct entities. DM1 is due to a mutation of the CTG expansion in DMPK, whereas DM2 is caused by a CCTG expansion in the CNBP gene ([@b9-mmr-16-04-3737]). DM2 is rarer and has a milder phenotype and later onset of symptoms, when compared with DM1 ([@b28-mmr-16-04-3737]). The DM1 repeat number increases over the generations. Conversely, the DM2 repeat number may decrease over the generations ([@b12-mmr-16-04-3737]). In addition to the common molecular mechanisms, differences do exist between DM1 and DM2 ([@b29-mmr-16-04-3737]). Franc *et al* ([@b30-mmr-16-04-3737]) demonstrated that the gray matter volumes are significantly decreased in DM1 patients, rather than in DM2 patients. Passeri *et al* ([@b31-mmr-16-04-3737]) identified that the phosphate levels are decreased in DM1 patients, but not in DM2 patients. In the present study, results of GO functional enrichment analysis indicated that the DEGs in DM1 cataracts may affect cell cycle, mRNA metabolic process and RNA processing, whereas the DEGs in DM2 cataract may be involved in regulation of apoptosis, regulation of programmed cell death and regulation of cell death. These results provide evidences in favor of the discrepancy in the underlying molecular mechanisms between DM1 and DM2 cataracts.

It has been presented that, in DM1, unstable CTG repeats in the DMPK gene induce mis-splicing to fetal/neonatal isoforms of many transcripts associated with cellular Ca2+ homeostasis, and several calcium-associated proteins are abnormally expressed in DM1 and DM2, including Ca^2+^ release channel ryanodine receptor and calsequestrin 2 ([@b32-mmr-16-04-3737]). Botta *et al* ([@b33-mmr-16-04-3737]) suggested that unbalanced Ca^2+^ homeostasis causes muscle degeneration in DM1 muscle cells by activating endoplasmic reticulum stress. In support of these findings, the present study indicated that DEGs in DM1 cataracts were significantly enriched in the calcium signaling pathway, indicating that this may serve a role in the pathogenesis of DM1 cataracts. Furthermore, results of the KEGG pathway enrichment analysis suggested that the Wnt axon guidance signaling pathways may be involved in DM1 cataract, whereas the adherens junction signaling pathway may be involved in DM2 cataracts. To the best of our knowledge, these findings have not been reported before.

miRNAs are highly conserved, noncoding RNAs that are involved in a wide range of biological processes, including myogenesis and muscle regeneration. The deregulation of miRNAs in the pathogenesis of MD has been an area of intense investigation. Perbellini *et al* ([@b34-mmr-16-04-3737]) discovered that miR-29b, miR-29c and miR-33 are downregulated in skeletal muscle biopsies of DM1 patients relative to controls. Greco *et al* ([@b35-mmr-16-04-3737]) created a list of dysregulated miRNAs in skeletal muscle biopsies of DM2 patients compared with controls, including miR-34a-5p, miR-34b-3p and miR-34c-5p. Furthermore, miR-206 is overexpressed in the skeletal muscle of DM1 patients ([@b36-mmr-16-04-3737]), and miR-1 is associated with heart defects in DM1 and DM2 ([@b37-mmr-16-04-3737]). However, the dysregulated miRNAs in the pathogenesis of DM1 and DM2 cataracts remain to be clearly defined. The present study suggested that miR-197, miR-29b, miR-29c, miR-130a and miR-130b are potentially involved in DM1 cataracts, while miR-197, miR-29c, miR-29a, miR-152, miR-302d, miR-372, miR-20a, miR-20b, miR-133a, miR-133b, miR-148a, miR-148b and miR-515-3p may be implicated in DM2 cataracts. miR-197 and miR-29c were involved in DM1 and DM2 cataracts. The present study added more insights concerning miRNA deregulation in the pathogenesis of DM.

The results of the current study advanced understanding of the molecular mechanisms underlying DM1 or DM2 cataracts. However, it had a limited sample size. More importantly, further experimental studies are warranted to verify these findings derived from the microarray data analysis.

In conclusion, the present study identified potential genes, pathways and upstream miRNAs, which may be involved in the pathogenesis of DM1 or DM2 cataracts. The calcium, Wnt and axon guidance signaling pathways, and miR-197, miR-29b and miR-29c, may be involved in DM1 cataracts. The adherens junction signaling pathway, miR-197, miR-29c and miR-29a may be involved in DM2 cataracts. Further studies are required to elucidate the different underlying molecular mechanisms between DM1 and DM2 cataracts, and to develop potential treatments for this disorder.

![An miRNA-gene network for DM1 cataracts. Square nodes denote genes and diamond-shaped nodes denote miRNAs. An undirected link represents an interaction between two genes, or between a gene and an miRNA. miRNA, microRNA; DM, myotonic dystrophy.](MMR-16-04-3737-g00){#f1-mmr-16-04-3737}

![miRNA-gene network for DM2 cataracts. Square nodes denote genes and diamond-shaped nodes denote miRNAs. An undirected link represents an interaction between two genes, or between a gene and an miRNA. miRNA, microRNA; DM, myotonic dystrophy.](MMR-16-04-3737-g01){#f2-mmr-16-04-3737}

![(A-C) A total of three modules extracted from the miRNA-gene network for DM1 cataract. Square nodes denote genes and diamond-shaped nodes denote miRNAs. An undirected link stands for an interaction between two genes, or between a gene and an miRNA. miRNA, microRNA; DM, myotonic dystrophy.](MMR-16-04-3737-g02){#f3-mmr-16-04-3737}

![(A-G) A total of seven modules extracted from the miRNA-gene network for DM2 cataracts. Square nodes represent genes and diamond-shaped nodes represent miRNAs. An undirected link refers to an interaction between two genes, or between a gene and an miRNA.](MMR-16-04-3737-g03){#f4-mmr-16-04-3737}

###### 

Significant GO terms for DEGs in DM1 cataracts.

  GO terms   Description                                        Count of genes   Q-value
  ---------- -------------------------------------------------- ---------------- -------------
  BP         Intracellular transport                            18               0.011184278
             Cell cycle                                         18               0.045910811
             mRNA metabolic process                             15               7.41E-04
             RNA processing                                     15               0.022266862
             Vesicle-mediated transport                         15               0.03260547
             mRNA processing                                    14               6.10E-04
             Protein folding                                    13               7.45E-06
             Cytoskeleton organization                          13               0.020266359
             Regulation of cellular protein metabolic process   13               0.035471916
             RNA splicing                                       12               0.002271744
  CC         Non-membrane-bounded organelle                     51               0.00607
             Intracellular non-membrane-bounded organelle       51               0.00607
             Membrane-enclosed lumen                            48               1.60E-05
             Organelle lumen                                    46               4.69E-05
             Intracellular organelle lumen                      45               5.82E-05
             Cytosol                                            32               0.002344
             Nuclear lumen                                      32               0.008374
             Vesicle                                            22               3.57E-04
             Membrane-bounded vesicle                           21               1.08E-04
             Cytoplasmic vesicle                                21               5.36E-04
  MF         Nucleotide binding                                 39               0.075474
             Purine ribonucleotide binding                      34               0.049174
             Ribonucleotide binding                             34               0.049174
             Purine nucleotide binding                          34               0.08014
             Nucleoside binding                                 30               0.063175
             ATP binding                                        29               0.039048
             Adenyl ribonucleotide binding                      29               0.045135
             Adenyl nucleotide binding                          29               0.076671
             Purine nucleoside binding                          29               0.088577
             RNA binding                                        20               0.003752

GO, gene ontology; DEG, differentially expressed genes; DM, myotonic dystrophy; BP, biological process; CC, cellular component; MF, molecular function.

###### 

Significant GO terms for DEGs in DM2 cataracts.

  GO term   Description                                    Gene count   Q-value
  --------- ---------------------------------------------- ------------ -------------
  BP        Regulation of apoptosis                        25           0.015950693
            Regulation of programmed cell death            25           0.017739841
            Regulation of cell death                       25           0.018408079
            Protein transport                              23           0.028778834
            Establishment of protein localization          23           0.031394209
            Intracellular transport                        22           0.011776008
            Vesicle-mediated transport                     19           0.023259474
            Membrane organization                          18           8.39E-04
            Protein complex assembly                       17           0.028082861
            Protein complex biogenesis                     17           0.028082861
  CC        Intracellular non-membrane-bounded Organelle   59           0.039736
            Non-membrane-bounded organelle                 59           0.039736
            Membrane-enclosed lumen                        57           4.79E-05
            Organelle lumen                                53           3.82E-04
            Intracellular organelle lumen                  52           4.07E-04
            Cytosol                                        48           4.18E-06
            Nuclear lumen                                  38           0.017793
            Organelle membrane                             34           0.002298
            Mitochondrion                                  30           0.020663
            Endomembrane system                            29           3.82E-04
  MF        Nucleotide binding                             53           0.037027
            Purine nucleotide binding                      44           0.085847
            Ribonucleotide binding                         42           0.096712
            Purine ribonucleotide binding                  42           0.096712
            Nucleoside binding                             39           0.057925
            Adenyl nucleotide binding                      38           0.064446
            Purine nucleoside binding                      38           0.076716
            ATP binding                                    36           0.063612
            Adenyl ribonucleotide binding                  36           0.073955
            RNA binding                                    26           0.001454

KEGG, Kyoto Encyclopedia of Genes and Genomes; DEG, differentially expressed genes; DM, myotonic dystrophy; BP, biological process; CC, cellular component; MF, molecular function; ATP, adenosine triphosphate.

###### 

KEGG pathways for DEGs in DM1 cataracts.

  KEGG           Gene count   Adjusted P-value   Description
  -------------- ------------ ------------------ -----------------------------------------
  KEGG_PATHWAY   5            0.020744           Long-term potentiation
  KEGG_PATHWAY   4            0.048553           Amyotrophic lateral sclerosis
  KEGG_PATHWAY   6            0.10831            Alzheimer\'s disease
  KEGG_PATHWAY   5            0.131481           Spliceosome
  KEGG_PATHWAY   6            0.137285           Calcium signaling pathway
  KEGG_PATHWAY   4            0.171196           Dilated cardiomyopathy
  KEGG_PATHWAY   5            0.206866           Wnt signaling pathway
  KEGG_PATHWAY   3            0.221622           Pathogenic *Escherichia coli* infection
  KEGG_PATHWAY   4            0.243621           Oocyte meiosis
  KEGG_PATHWAY   4            0.32439            Axon guidance

KEGG, Kyoto Encyclopedia of Genes and Genomes; DEG, differentially expressed genes; DM, myotonic dystrophy.

###### 

KEGG pathways for DEGs in DM2 cataracts.

  KEGG           Gene count   Q-value    Description
  -------------- ------------ ---------- -----------------------------------------
  KEGG_PATHWAY   10           0.013726   Huntington\'s disease
  KEGG_PATHWAY     4          0.037286   Basal transcription factors
  KEGG_PATHWAY     7          0.053893   Parkinson\'s disease
  KEGG_PATHWAY     5          0.080184   Adherens junction
  KEGG_PATHWAY     4          0.101893   Amyotrophic lateral sclerosis
  KEGG_PATHWAY     4          0.106299   Non-small cell lung cancer
  KEGG_PATHWAY     4          0.119952   Pathogenic *Escherichia coli* infection
  KEGG_PATHWAY     2          0.120912   Methane metabolism
  KEGG_PATHWAY     7          0.131916   Alzheimer\'s disease
  KEGG_PATHWAY     4          0.14904    Glioma

KEGG, Kyoto Encyclopedia of Genes and Genomes; DEG, differentially expressed genes; DM, myotonic dystrophy.
